Medical Council of Canada · Canada
MCCQE Part I
Presentation-based examination combining multiple-choice questions with clinical decision-making cases, mapped to the MCC objectives and CanMEDS roles.
Blueprint reference
MCC Examination Objectives (clinical presentations framework)
Official blueprints are used as structural metadata only. Questions and explanations are written for Med Intelligence; no commercial question bank content is reproduced.
Subjects and high-yield points
3 subjectsClinical presentations
Topics
Chest pain · Dyspnoea · Fever · Oliguria · Hyperglycaemia
High yield
- Structured approach: history, examination, red flags, initial tests, differential
- Choosing site of care with CURB-65 and clinical judgement
Population health & ethics
Topics
Screening principles · Immunisation · Informed consent · Cultural safety
High yield
- Screening criteria and lead-time bias
- Duty to report communicable disease
Therapeutics
Topics
Anticoagulation decisions · Diabetes escalation · Antibiotic stewardship
High yield
- CHA₂DS₂-VASc thresholds by sex
- HAS-BLED modifies risk factors, never withholds anticoagulation
Revision cards
3 cardsPractice questions
Original itemsA 19-year-old with type 1 diabetes has glucose 32 mmol/L, capillary ketones 5.8 mmol/L, pH 7.05 and potassium 3.2 mmol/L. He has received 1 L of 0.9% sodium chloride. What should happen next?
A 68-year-old woman with hypertension and type 2 diabetes has newly diagnosed non-valvular atrial fibrillation. HAS-BLED is 3, driven by blood pressure of 168/96 mmHg and regular ibuprofen use. What is the most appropriate management?
A 76-year-old on ramipril, furosemide and ibuprofen presents with diarrhoea. Creatinine has risen from 90 to 210 µmol/L and she is clinically hypovolaemic. What is the most appropriate first step?
A 72-year-old woman has right-sided weakness and expressive aphasia that began 2 hours ago. CT shows no haemorrhage, blood pressure is 168/92 mmHg and glucose is 6.8 mmol/L. What is the next step?
Demo content. Educational decision support only. Verify every dose, citation and recommendation against your national formulary and the primary source before clinical use.